TMAO Test

Your cholesterol numbers can look perfect and still leave you exposed. TMAO (trimethylamine N-oxide) is a metabolite your body produces from everyday foods, and it tracks a dimension of cardiovascular risk that lipid panels, blood sugar tests, and even inflammatory markers do not capture. In large studies following tens of thousands of people for over a decade, those with the highest TMAO levels faced roughly 30 to 60% greater risk of heart attack, stroke, and death, even after accounting for every traditional risk factor.

What makes TMAO unusual is that it sits at the intersection of three systems: your diet, your gut bacteria, and your kidneys. It is not a single organ's output. It is a composite signal reflecting how well those systems are working together, and whether they are quietly tilting your biology toward or away from vascular damage.

How Your Body Makes TMAO

When you eat foods rich in choline (eggs, liver), carnitine (red meat), or betaine, bacteria in your large intestine convert these nutrients into a gas called TMA (trimethylamine). TMA travels to your liver, where an enzyme called FMO3 (flavin-containing monooxygenase 3) converts it into TMAO. Your kidneys then clear most of the TMAO into your urine, typically within about 24 hours.

Fish is a special case. It contains preformed TMAO that gets absorbed directly into your bloodstream without needing gut bacteria to produce it. This is why eating fish can spike your TMAO temporarily, even though fish consumption is consistently linked to better heart health. This paradox is one of the reasons TMAO should never be interpreted on its own.

Heart Disease and Cardiovascular Events

The cardiovascular signal from TMAO is the most studied and the most consistent. A major meta-analysis pooling 44 cohorts and over 84,000 people found that higher TMAO was associated with about 29% higher risk of cardiovascular disease overall, 51% higher risk of cardiovascular death, and 30% higher risk of dying from any cause. These associations held after adjusting for the usual suspects: age, blood pressure, cholesterol, diabetes, and smoking.

In people who already have heart disease, the signal is even stronger. Among over 2,200 patients presenting with chest pain or acute coronary syndromes, those in the highest quarter of TMAO had roughly six times the odds of a major cardiovascular event within 30 days compared to those in the lowest quarter, and nearly double the risk of death over the following seven years. A separate analysis of patients after coronary stent procedures found that each 1 µM increase in TMAO was linked to about 9% higher risk of a future cardiovascular event.

If your TMAO comes back elevated alongside other concerning markers (high ApoB, elevated hs-CRP, or borderline blood sugar), that combination paints a much more complete picture of your vascular risk than any single number. If TMAO is the only marker that is elevated, a retest after dietary changes is a reasonable next step before escalating to further workup.

Heart Failure

In chronic heart failure, TMAO levels tend to be markedly elevated and predict worse outcomes. A study of over 3,200 heart failure patients (the BIOSTAT-CHF cohort) found that higher TMAO at baseline predicted death and rehospitalization over one to three years. An important finding from this study: standard heart failure medications (ACE inhibitors, beta-blockers, diuretics) improved the heart's pumping-strain marker BNP but did not lower TMAO, suggesting it reflects a separate biological process that standard therapy does not address.

Kidney Disease and Kidney Function

Because your kidneys are the main exit route for TMAO, kidney function is the single biggest determinant of your circulating level. As kidney filtration rate (eGFR) drops, TMAO accumulates. In a study of 521 people with chronic kidney disease (CKD), those in the highest quarter of TMAO had roughly twice the risk of dying over five years compared to those in the lowest quarter, even after adjusting for kidney function and inflammation.

The relationship runs both directions. In 440 people with type 2 diabetes, those in the highest third of TMAO (roughly 0.88 µM and above) faced about a six-fold increase in the risk of rapidly losing kidney function or reaching end-stage kidney disease. This makes TMAO particularly useful for anyone with early kidney concerns or diabetes: it can flag accelerating kidney trouble before standard kidney markers move.

Metabolic Health and Body Weight

TMAO is not just a cardiovascular marker. A dose-response meta-analysis found a positive, graded association between TMAO levels and body mass index (BMI) in apparently healthy adults. In a study of over 2,600 people across both clinical and population-based German cohorts, TMAO was independently associated with obesity and diabetes after adjusting for other risk factors. A separate cohort of over 2,000 diabetes-free Chinese adults followed for nearly nine years found that those in the highest third of baseline TMAO had 42% greater risk of developing type 2 diabetes.

The Fish Paradox and How to Read Your Result

One of the most common sources of confusion with TMAO is the fish effect. Eating fish raises TMAO far more acutely than eating red meat or eggs, sometimes by 40 to 60 times above baseline within hours. Yet fish consumption is consistently associated with lower cardiovascular risk. This is not actually contradictory once you understand the mechanism: fish delivers preformed TMAO that is rapidly cleared by the kidneys, while red meat provides carnitine that gut bacteria slowly and persistently convert into TMA. The chronic, bacteria-driven production from red meat appears to be the metabolically relevant signal, not the transient spike from fish.

This means a single TMAO reading taken the morning after a fish dinner can be misleading. For the most accurate picture, avoid fish for at least 24 hours before your blood draw.

Reference Ranges

There is no universally standardized clinical reference range for TMAO. The ranges below are drawn from large prospective cohorts and meta-analyses involving primarily middle-aged adults of European and Asian ancestry, measured by liquid chromatography-mass spectrometry (LC-MS). Your lab may report results in slightly different units or use different methods. Compare your results within the same lab over time for the most meaningful trend.

Age strongly shifts the distribution: average levels rise from roughly 2.5 µM in younger adults to about 10 µM in older adults, partly reflecting declining kidney function. There are no well-validated sex-specific or ethnicity-specific cutpoints at this time.

When Results Can Be Misleading

TMAO is one of the more variable biomarkers you can order. Long-term within-person correlation is modest (around 0.25 in one large cohort with repeat measures seven years apart), meaning a single reading can be substantially different from your true average. The biggest confounders to watch for:

• Recent fish intake: Fish can raise TMAO 40 to 60 times above baseline within hours. Avoid fish for at least 24 hours before your draw.
• Kidney function: Even mild reductions in kidney filtration can raise TMAO significantly. Always interpret TMAO alongside eGFR or cystatin C.
• Acute illness or surgery: TMAO levels shift during and after acute events like stroke or heart surgery, falling in the first 48 hours and then rebounding over weeks to months.
• Broad-spectrum antibiotics: These can markedly suppress TMAO by wiping out the gut bacteria that produce TMA. If you have taken antibiotics in the past two to four weeks, your reading may be artificially low.

Tracking Your Trend

Because of TMAO's high day-to-day variability, a single reading is best treated as a starting point, not a verdict. If your result falls in the moderate or elevated range, a retest in three to six months (after making dietary changes and confirming stable kidney function) will tell you far more than the first number alone. If you are making deliberate shifts in your diet, like reducing red meat or increasing plant-based meals, a follow-up TMAO test is one of the few ways to see whether your gut microbiome is actually responding to those changes.

For ongoing monitoring, test at least annually if you have any cardiometabolic risk factors. If your levels are in the lower-risk range and your diet is stable, every one to two years is reasonable. The goal is to build a personal trend line rather than to react to any single data point.

What to Do With an Abnormal Result

If your TMAO comes back above 8 µM, start with context. Check your kidney function (eGFR or cystatin C) and recall what you ate in the 24 hours before your blood draw. If kidney function is normal and you did not eat fish recently, the elevation likely reflects a combination of your diet, your gut microbiome's composition, and your metabolic health.

Pair TMAO with a heart health panel (ApoB, hs-CRP, HbA1c, lipids) to see whether it fits into a broader pattern of elevated risk. If multiple markers are concerning, consider involving a cardiologist or lipidologist. If TMAO is isolated, dietary modification focused on reducing red meat and increasing fiber-rich plant foods is the most evidence-supported first step. Retest in three to six months to see if the change registered.

For results above 20 µM, kidney function should be evaluated thoroughly if it has not been already. This level is common in people with unrecognized kidney impairment, and addressing the underlying kidney issue will often bring TMAO down as well.